Richard R Kew1, Tahmineh Tabrizian, James A Vosswinkel, James E Davis, Randeep S Jawa. 1. From the Department of Pathology (R.R.K., T.T., J.E.D.), Stony Brook University School of Medicine, Stony Brook, New York; and Division of Trauma, Department of Surgery (J.A.V., R.S.J.), Stony Brook University School of Medicine, Stony Brook, New York.
Abstract
BACKGROUND: Severe acute muscle injury results in massive cell damage, causing the release of actin into extracellular fluids where it complexes with the vitamin D-binding protein (DBP). We hypothesized that a systemic DBP deficiency would result in a less proinflammatory phenotype. METHODS: C57BL/6 wild-type (WT) and DBP-deficient (DBP-/-) mice received intramuscular injections of either 50% glycerol or phosphate-buffered saline into thigh muscles. Muscle injury was assessed by histology. Cytokine levels were measured in plasma, muscle, kidney, and lung. RESULTS: All animals survived the procedure, but glycerol injection in both strains of mice showed lysis of skeletal myocytes and inflammatory cell infiltrate. The muscle inflammatory cell infiltrate in DBP-deficient mice had remarkably few neutrophils as compared with WT mice. The neutrophil chemoattractant CXCL1 was significantly reduced in muscle tissue from DBP-/- mice. However, there were no other significant differences in muscle cytokine levels. In contrast, plasma obtained 48 hours after glycerol injection revealed that DBP-deficient mice had significantly lower levels of systemic cytokines interleukin 6, CCL2, CXCL1, and granulocyte colony-stimulating factor. Lung tissue from DBP-/- mice showed significantly decreased amounts of CCL2 and CXCL1 as compared with glycerol-treated WT mice. Several chemokines in kidney homogenates following glycerol-induced injury were significantly reduced in DBP-/- mice: CCL2, CCL5, CXCL1, and CXCL2. CONCLUSIONS: Acute muscle injury triggered a systemic proinflammatory response as noted by elevated plasma cytokine levels. However, mice with a systemic DBP deficiency demonstrated a change in their cytokine profile 48 hours after muscle injury to a less proinflammatory phenotype.
BACKGROUND: Severe acute muscle injury results in massive cell damage, causing the release of actin into extracellular fluids where it complexes with the vitamin D-binding protein (DBP). We hypothesized that a systemic DBP deficiency would result in a less proinflammatory phenotype. METHODS: C57BL/6 wild-type (WT) and DBP-deficient (DBP-/-)mice received intramuscular injections of either 50% glycerol or phosphate-buffered saline into thigh muscles. Muscle injury was assessed by histology. Cytokine levels were measured in plasma, muscle, kidney, and lung. RESULTS: All animals survived the procedure, but glycerol injection in both strains of mice showed lysis of skeletal myocytes and inflammatory cell infiltrate. The muscle inflammatory cell infiltrate in DBP-deficientmice had remarkably few neutrophils as compared with WT mice. The neutrophil chemoattractant CXCL1 was significantly reduced in muscle tissue from DBP-/-mice. However, there were no other significant differences in muscle cytokine levels. In contrast, plasma obtained 48 hours after glycerol injection revealed that DBP-deficientmice had significantly lower levels of systemic cytokines interleukin 6, CCL2, CXCL1, and granulocyte colony-stimulating factor. Lung tissue from DBP-/-mice showed significantly decreased amounts of CCL2 and CXCL1 as compared with glycerol-treated WT mice. Several chemokines in kidney homogenates following glycerol-induced injury were significantly reduced in DBP-/-mice: CCL2, CCL5, CXCL1, and CXCL2. CONCLUSIONS: Acute muscle injury triggered a systemic proinflammatory response as noted by elevated plasma cytokine levels. However, mice with a systemic DBP deficiency demonstrated a change in their cytokine profile 48 hours after muscle injury to a less proinflammatory phenotype.
Authors: Marius Papurica; Alexandru F Rogobete; Dorel Sandesc; Carmen A Cradigati; Mirela Sarandan; Raluca Dumache; Florin G Horhat; Lavinia M Bratu; Razvan Nitu; Dan C Crisan; Delia I Horhat; Elena S Popovici; Sonia Tanasescu; Vlad Daliborca; Ovidiu Boruga; Ovidiu H Bedreag Journal: Clin Lab Date: 2016-10-01 Impact factor: 1.138
Authors: Junjie Mei; Yuhong Liu; Ning Dai; Christian Hoffmann; Kristin M Hudock; Peggy Zhang; Susan H Guttentag; Jay K Kolls; Paula M Oliver; Frederic D Bushman; G Scott Worthen Journal: J Clin Invest Date: 2012-02-13 Impact factor: 14.808
Authors: Benny Dahl; Frank V Schiødt; Peter Ott; Frank Wians; William M Lee; Jody Balko; Grant E O'Keefe Journal: Crit Care Med Date: 2003-01 Impact factor: 7.598
Authors: Glenda Trujillo; David M Habiel; Lingyin Ge; Mahalakshmi Ramadass; Nancy E Cooke; Richard R Kew Journal: J Immunol Date: 2013-06-10 Impact factor: 5.422